|
Mr. Williams has served as Vice President Manufacturing and Technical Operations of Cardium Therapeutics since November 2005 and as Vice President Manufacturing and Technical Operations of InnerCool Therapies since it was acquired by Cardium in March 2006. Mr. Williams brings over 25 years of professional experience in FDA-regulated environments of biopharmaceutical process development, cGMP manufacturing, quality assurance and control, microbiology, raw materials testing and analytical methods development. Prior to joining Cardium Therapeutics, Mr. Williams was Senior Director of Quality Control at Favrille, Inc., a publicly-traded biotechnology company. From 2001 to 2004, he was Director of Research Operations, Process Technologies and Quality Systems at Collateral Therapeutics where he was involved in research and development efforts related to Generx and other product candidates. Mr. Williams was Senior Manager of Quality Systems at Advanced Tissue Sciences from 1998 to 2001, Manager of Quality Control at Chiron Technologies, Center for Gene Therapy from 1995 to 1998, and Supervisor of Quality Control at Viagene Inc. from 1992 to 1995. From 1978 to 1992, he was Chief Microbiologist and Supervisor of the Clinical Microbiology Department at Yuma Regional Medical Center. Mr. Williams earned his B.S. in microbiology from Weber State University, Ogden, Utah. | 